Of Rs 2 per share
Glenmark Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 08 May 2014, inter alia, has recommended dividend @ 200% i.e. Rs 2 per share (face value Re 1) on the equity share capital of the Company for the financial year 2013-2014 subject to the approval of the shareholders at the ensuing Annual General Meeting.Powered by Capital Market - Live News
